May 07, 2019
Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights
Mar 14, 2019
Ardelyx Appoints Renowned Nephrologist, Geoffrey A. Block, M.D., to Its Board of Directors
Mar 07, 2019
Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia in the Journal of the American Society of Nephrology
Mar 06, 2019
Ardelyx Reports Fourth Quarter 2018 Financial Results and Recent Highlights
Feb 21, 2019
Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare Conference
Feb 07, 2019
Ardelyx Collaboration Partner, Kyowa Hakko Kirin, Announces Initiation of a Phase 2 Clinical Study of Tenapanor for Hyperphosphatemia Patients on Dialysis in Japan
Nov 13, 2018
Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with IBS-C
Nov 07, 2018
Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights
Oct 26, 2018
Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Elevated Serum Phosphorus
Oct 08, 2018
Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting
Oct 04, 2018
Ardelyx to Host Its First Annual Investor Day Focused on Treatment Landscape of Renal Disorders
Sep 13, 2018
Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
Aug 07, 2018
Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights
Aug 01, 2018
Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call
May 29, 2018
Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference
May 22, 2018
Ardelyx Announces Pricing of Public Offering of Common Stock
May 21, 2018
Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank
May 21, 2018
Ardelyx Announces Proposed Public Offering of Common Stock
May 08, 2018
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights
Mar 19, 2018
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada